News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Publication May 14, 2019 Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease Christopher Ma, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 Update on C-Reactive Protein and Fecal Calprotectin: Are They Accurate Measures of Disease Activity in Crohn’s Disease? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Systematic Review With Meta-Analysis: Efficacy and Safety of Oral Janus Kinase Inhibitors for Inflammatory Bowel Disease Brian Feagan, Christopher Ma, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 IL12/23 or Selective IL23 Inhibition for the Management of Moderate-To-Severe Crohn’s Disease? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Identifying Outcomes in Clinical Trials of Fistulizing Crohn’s Disease for the Development of a Core Outcome Set Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Evaluation of Optimal Biopsy Location for Assessment of Histological Activity, Transcriptomic and Immunohistochemical Analyses in Patients With Active Crohn’s Disease Brian Feagan, Geert D’Haens, Guangyong Zou, Niels Vande Casteele, Vipul Jairath Read Now
